Skip to content
Home/Companies/Biotech/Glionova AB

Glionova AB

Biotech·Sweden·Active·12yr hold
Entry
2014
Hold
12yr
Status
Active

Who owns Glionova AB?

Glionova AB is a Swedish Biotech company, currently owned by HealthCap since 2014.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VI · 2008 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from HealthCap VI

Other portfolio companies in the same fund.

GenSight Biologics S.A.
Exited 2016
BiotechFrance· 2015
Xeris Biopharma Holdings, Inc (Strongbridge)
Exited 2021
PharmaUS· 2014
to Xeris Pharmaceuticals
Nordic Nanovector AS
Exited 2015
BiotechNO· 2013
Oncopeptides AB
Exited 2017
BiotechSE· 2013
Wilson Therapeutics AB
Exited 2018
PharmaSweden· 2012
to Alexion Pharmaceuticals
Ultragenyx
Exited 2014
BiotechUS· 2011

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Glionova AB?

Glionova AB is currently owned by HealthCap, through HealthCap VI, since 2014.

When did HealthCap acquire Glionova AB?

HealthCap acquired Glionova AB in 2014.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue